Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
Zoetis (ZTS) closed at $74.07 in the latest trading session, marking a -1.75% move from the prior day.
ZTS - Zoetis Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$110.57
DETAILS
HIGH:
$160.00
LOW:
$85.00
MEDIAN:
$99.00
CONSENSUS:
$110.57
UPSIDE:
49.28%
Stock News
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines – ZTS
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. com or 646-581-9980, (or 888. 4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines – ZTS
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ZTS
New York, New York--(Newsfile Corp. - July 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, July 14, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming July 27, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS) securities between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”).
ZTS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Zoetis Inc. Securities Lawsuit - Contact SueWallSt
Zoetis CEO Kristin Peck and CFO Wetteny Joseph Face Personal Liability for Allegedly Certifying Misleading Statements About Companion Animal Product Performance While Safety Concerns and Competitive Losses Mounted Zoetis CEO Kristin Peck and CFO Wetteny Joseph Face Personal Liability for Allegedly Certifying Misleading Statements About Companion Animal Product Performance While Safety Concerns and Competitive Losses Mounted
ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm
NEW YORK, July 14, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zoetis Inc. (NYSE: ZTS). Shareholders who purchased shares of ZTS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Portnoy Law Firm Announces Class Action on Behalf of Zoetis, Inc. Investors
LOS ANGELES, July 14, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Zoetis, Inc., (“Zoetis” or the "Company") (NYSE: ZTS) investors of a class action on behalf of investors that bought securities between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”). Zoetis investors have until July 27, 2026 to file a lead plaintiff motion.
Zoetis Announces Agreement to Acquire VitalRADS, Accelerating Diagnostic Capabilities
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. today announced its agreement to acquire VitalRADS, a veterinary teleradiology services platform. Building on the partnership with VitalRADS that Zoetis announced in August 2025, this acquisition adds around-the-clock access to board-certified veterinary specialists through a cloud-based teleradiology platform. Integrating VitalRADS' capabilities into Zoetis' Global Diagnostics portfolio enhances Zoetis' reference laboratory services, delivering AI.
Zoetis: Buy When There Is Blood In The Streets
Zoetis has long been viewed as a high-quality compounder. However, after reaching an all-time high of $249.27 in December 2021, the stock is now caught in a ~70% drawdown. This can be primarily attributed to the dismal performance of the company's crown jewel asset, namely the U.S. companion animal business. After delivering an impressive 25% organic growth during the full year of 2021, the U.S. companion animal business reported dismal performance in Q1-26, with an organic decline of 11%.
Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026, both dates inclusive (the “Class Period”).
ZTS Shareholder Alert: July 27, 2026 Lead Plaintiff Deadline in Zoetis Inc. Securities Class Action - Contact Levi & Korsinsky
NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP highlights the contrast between Zoetis Inc.'s (NYSE: ZTS) promises to investors and the reality that emerged across four corrective disclosures. Shareholders who purchased ZTS securities between January 14, 2025 and May 6, 2026 and suffered losses may be entitled to compensation.
Zoetis Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ZTS
LOS ANGELES, July 13, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Zoetis Inc. ("Zoetis" or "the Company") (NYSE: ZTS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of ZTS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, July 13, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Zoetis Inc. ("Zoetis" or "the Company") (NYSE: ZTS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), are encouraged to contact the firm before July 27, 2026.
ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ZTS
New York, New York--(Newsfile Corp. - July 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New York, New York--(Newsfile Corp. - July 12, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026, both dates inclusive (the "Class Period").
ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ZTS
New York, New York--(Newsfile Corp. - July 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
10 Dividend Growth Stocks: July 2026
I define dividend growth stocks as those with dividend increases of 5 or more consecutive years. In this monthly series, I rank a selection of dividend growth stocks and present the top 10 stocks for consideration. This month, I'm presenting the top 10 dividend growth stocks with a 5-year yield-on-cost of 2.5% or higher and a consensus upside of at least 5%.
Zoetis Deadline: ZTS Investors with Losses in Excess of $100K Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit
NEW YORK, July 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. So What: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
ZOETIS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS
NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”), of the important July 27, 2026 lead plaintiff deadline.
Price Targets
Zoetis price target lowered to $95 from $140 at HSBC
$95.00
(was $74.63)
HSBC
Zoetis price target lowered to $85 from $136 at Barclays
$85.00
(was $71.91)
Barclays
Zoetis price target lowered to $85 from $95 at Stifel
$85.00
(was $77.82)
Stifel Nicolaus
Zoetis price target lowered to $95 from $105 at Stifel
$95.00
(was $80.06)
Stifel Nicolaus
Zoetis price target lowered to $115 from $160 at Morgan Stanley
$115.00
(was $76.06)
Erin Wright
·
Morgan Stanley
Zoetis price target lowered to $99 from $130 at UBS
$99.00
(was $83.27)
UBS
Zoetis price target lowered to $105 from $130 at Stifel
$105.00
(was $87.31)
Stifel Nicolaus
Zoetis price target lowered to $130 from $136 at UBS
$130.00
(was $116.71)
UBS
BTIG Reiterates Buy Rating on Zoetis Inc. (ZTS)
$160.00
(was $128.95)
Mark Massaro
·
BTIG
Zoetis price target lowered to $136 from $141 at UBS
$136.00
(was $122.75)
UBS
Piper Sandler Downgrades Zoetis Inc. (ZTS) to Neutral
$135.00
(was $125.08)
David Westenberg
·
Piper Sandler
Zoetis price target lowered to $160 from $175 at Morgan Stanley
$160.00
(was $124.54)
Morgan Stanley
Zoetis price target lowered to $140 from $180 at HSBC
$140.00
(was $115.75)
HSBC
Zoetis initiated with an Equal Weight at Barclays
$136.00
(was $118.16)
Barclays
Zoetis price target lowered to $140 from $155 at Stifel
$140.00
(was $125.50)
Stifel Nicolaus
Zoetis price target lowered to $158 from $165 at UBS
$158.00
(was $144.90)
UBS
Zoetis price target raised to $215 from $210 at Piper Sandler
$215.00
(was $148.86)
David Westenberg
·
Piper Sandler
Zoetis downgraded to Hold from Buy at Stifel
$160.00
(was $161.67)
Jonathan Block
·
Stifel Nicolaus
Zoetis price target lowered to $170 from $189 at UBS
$170.00
(was $149.87)
Andrea Alfonso
·
UBS
Zoetis price target lowered to $165 from $180 at Stifel
$165.00
(was $150.83)
Jonathan Block
·
Stifel Nicolaus